Literature DB >> 12370288

Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha.

Constantinos Koumenis1, Christine Naczki, Marianne Koritzinsky, Sally Rastani, Alan Diehl, Nahum Sonenberg, Antonis Koromilas, Bradly G Wouters.   

Abstract

Hypoxia profoundly influences tumor development and response to therapy. While progress has been made in identifying individual gene products whose synthesis is altered under hypoxia, little is known about the mechanism by which hypoxia induces a global downregulation of protein synthesis. A critical step in the regulation of protein synthesis in response to stress is the phosphorylation of translation initiation factor eIF2alpha on Ser51, which leads to inhibition of new protein synthesis. Here we report that exposure of human diploid fibroblasts and transformed cells to hypoxia led to phosphorylation of eIF2alpha, a modification that was readily reversed upon reoxygenation. Expression of a transdominant, nonphosphorylatable mutant allele of eIF2alpha attenuated the repression of protein synthesis under hypoxia. The endoplasmic reticulum (ER)-resident eIF2alpha kinase PERK was hyperphosphorylated upon hypoxic stress, and overexpression of wild-type PERK increased the levels of hypoxia-induced phosphorylation of eIF2alpha. Cells stably expressing a dominant-negative PERK allele and mouse embryonic fibroblasts with a homozygous deletion of PERK exhibited attenuated phosphorylation of eIF2alpha and reduced inhibition of protein synthesis in response to hypoxia. PERK(-/-) mouse embryo fibroblasts failed to phosphorylate eIF2alpha and exhibited lower survival after prolonged exposure to hypoxia than did wild-type fibroblasts. These results indicate that adaptation of cells to hypoxic stress requires activation of PERK and phosphorylation of eIF2alpha and suggest that the mechanism of hypoxia-induced translational attenuation may be linked to ER stress and the unfolded-protein response.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12370288      PMCID: PMC135664          DOI: 10.1128/MCB.22.21.7405-7416.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  74 in total

Review 1.  Initiation of translation in prokaryotes and eukaryotes.

Authors:  M Kozak
Journal:  Gene       Date:  1999-07-08       Impact factor: 3.688

2.  Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase.

Authors:  A E Koromilas; S Roy; G N Barber; M G Katze; N Sonenberg
Journal:  Science       Date:  1992-09-18       Impact factor: 47.728

Review 3.  Pulmonary hypertension due to chronic hypoxia.

Authors:  A Peacock
Journal:  BMJ       Date:  1990-03-24

4.  Oxygen dependent regulation of DNA synthesis and growth of Ehrlich ascites tumor cells in vitro and in vivo.

Authors:  H Probst; H Schiffer; V Gekeler; H Kienzle-Pfeilsticker; U Stropp; K E Stötzer; I Frenzel-Stötzer
Journal:  Cancer Res       Date:  1988-04-15       Impact factor: 12.701

Review 5.  PKR: a new name and new roles.

Authors:  C G Proud
Journal:  Trends Biochem Sci       Date:  1995-06       Impact factor: 13.807

6.  Oxygen effects in radiobiology.

Authors:  C J Koch
Journal:  Adv Exp Med Biol       Date:  1982       Impact factor: 2.622

7.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

8.  Fast control of DNA replication in response to hypoxia and to inhibited protein synthesis in CCRF-CEM and HeLa cells.

Authors:  G Probst; H J Riedinger; P Martin; M Engelcke; H Probst
Journal:  Biol Chem       Date:  1999-12       Impact factor: 3.915

Review 9.  The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.

Authors:  J M Brown; A J Giaccia
Journal:  Cancer Res       Date:  1998-04-01       Impact factor: 12.701

10.  Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix.

Authors:  M Höckel; C Knoop; K Schlenger; B Vorndran; E Baussmann; M Mitze; P G Knapstein; P Vaupel
Journal:  Radiother Oncol       Date:  1993-01       Impact factor: 6.280

View more
  267 in total

1.  The role of PERK and GCN2 in basal and hydrogen peroxide-regulated translation from the hepatitis C virus internal ribosome entry site.

Authors:  Samantha C Jack; Shiu-Wan Chan
Journal:  Virus Genes       Date:  2011-06-03       Impact factor: 2.332

2.  Global protein synthesis in human trophoblast is resistant to inhibition by hypoxia.

Authors:  S F Williams; E Fik; S Zamudio; N P Illsley
Journal:  Placenta       Date:  2011-11-10       Impact factor: 3.481

3.  Differential transcriptomic analysis of spontaneous lung tumors in B6C3F1 mice: comparison to human non-small cell lung cancer.

Authors:  Arun R Pandiri; Robert C Sills; Vincent Ziglioli; Thai-Vu T Ton; Hue-Hua L Hong; Stephanie A Lahousse; Kevin E Gerrish; Scott S Auerbach; Keith R Shockley; Pierre R Bushel; Shyamal D Peddada; Mark J Hoenerhoff
Journal:  Toxicol Pathol       Date:  2012-06-11       Impact factor: 1.902

4.  Definition of genetic events directing the development of distinct types of brain tumors from postnatal neural stem/progenitor cells.

Authors:  Falk Hertwig; Katharina Meyer; Sebastian Braun; Sara Ek; Rainer Spang; Cosima V Pfenninger; Isabella Artner; Gaëlle Prost; Xinbin Chen; Jaclyn A Biegel; Alexander R Judkins; Elisabet Englund; Ulrike A Nuber
Journal:  Cancer Res       Date:  2012-06-20       Impact factor: 12.701

5.  Protein misfolding induces hypoxic preconditioning via a subset of the unfolded protein response machinery.

Authors:  Xianrong R Mao; C Michael Crowder
Journal:  Mol Cell Biol       Date:  2010-08-23       Impact factor: 4.272

6.  Prolyl hydroxylase-dependent modulation of eukaryotic elongation factor 2 activity and protein translation under acute hypoxia.

Authors:  Antonio Romero-Ruiz; Lucía Bautista; Virginia Navarro; Antonio Heras-Garvín; Rosana March-Díaz; Antonio Castellano; Raquel Gómez-Díaz; María J Castro; Edurne Berra; José López-Barneo; Alberto Pascual
Journal:  J Biol Chem       Date:  2012-02-03       Impact factor: 5.157

7.  Structural determinants of PERK inhibitor potency and selectivity.

Authors:  Hong Wang; Jaime Blais; David Ron; Timothy Cardozo
Journal:  Chem Biol Drug Des       Date:  2010-12       Impact factor: 2.817

8.  Survival from hypoxia in C. elegans by inactivation of aminoacyl-tRNA synthetases.

Authors:  Lori L Anderson; Xianrong Mao; Barbara A Scott; C Michael Crowder
Journal:  Science       Date:  2009-01-30       Impact factor: 47.728

9.  Characterization of stanniocalcin 2, a novel target of the mammalian unfolded protein response with cytoprotective properties.

Authors:  Daisuke Ito; John R Walker; Charlie S Thompson; Isabella Moroz; William Lin; Margaret L Veselits; Antoine M Hakim; Allen A Fienberg; Gopal Thinakaran
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

10.  Development of a stress response therapy targeting aggressive prostate cancer.

Authors:  Hao G Nguyen; Crystal S Conn; Yae Kye; Lingru Xue; Craig M Forester; Janet E Cowan; Andrew C Hsieh; John T Cunningham; Charles Truillet; Feven Tameire; Michael J Evans; Christopher P Evans; Joy C Yang; Byron Hann; Constantinos Koumenis; Peter Walter; Peter R Carroll; Davide Ruggero
Journal:  Sci Transl Med       Date:  2018-05-02       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.